4//SEC Filing
MPM BIOVENTURES I LP 4
Accession 0001209191-08-038435
CIK 0001301081other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 6:13 PM ET
Size
29.4 KB
Accession
0001209191-08-038435
Insider Transaction Report
Form 4
Pharmasset IncVRUS
BB BIOVENTURES L P
10% Owner
Transactions
- Sale
Common Stock
2008-06-19$20.00/sh−1,400$28,000→ 2,118,331 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.91/sh−500$9,955→ 2,119,931 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.92/sh−100$1,992→ 2,119,831 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.90/sh−153,700$3,058,630→ 2,120,431 total(indirect: See Footnote)
MPM BIO VENTURES I LLC
10% Owner
Transactions
- Sale
Common Stock
2008-06-19$19.92/sh−100$1,992→ 2,119,831 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.90/sh−153,700$3,058,630→ 2,120,431 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$20.00/sh−1,400$28,000→ 2,118,331 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.91/sh−500$9,955→ 2,119,931 total(indirect: See Footnote)
STEINMETZ MICHAEL
10% Owner
Transactions
- Sale
Common Stock
2008-06-19$19.92/sh−100$1,992→ 2,119,831 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$20.00/sh−1,400$28,000→ 2,118,331 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.91/sh−500$9,955→ 2,119,931 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.90/sh−153,700$3,058,630→ 2,120,431 total(indirect: See Footnote)
BAB BIO VENTURES LLP
10% Owner
Transactions
- Sale
Common Stock
2008-06-19$19.91/sh−500$9,955→ 2,119,931 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$20.00/sh−1,400$28,000→ 2,118,331 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.92/sh−100$1,992→ 2,119,831 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.90/sh−153,700$3,058,630→ 2,120,431 total(indirect: See Footnote)
BAB BIO VENTURES NV
10% Owner
Transactions
- Sale
Common Stock
2008-06-19$19.92/sh−100$1,992→ 2,119,831 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.91/sh−500$9,955→ 2,119,931 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$20.00/sh−1,400$28,000→ 2,118,331 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.90/sh−153,700$3,058,630→ 2,120,431 total(indirect: See Footnote)
MPM BIOVENTURES PARALLEL FUND L P
10% Owner
Transactions
- Sale
Common Stock
2008-06-19$19.90/sh−153,700$3,058,630→ 2,120,431 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.92/sh−100$1,992→ 2,119,831 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.91/sh−500$9,955→ 2,119,931 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$20.00/sh−1,400$28,000→ 2,118,331 total(indirect: See Footnote)
Transactions
- Sale
Common Stock
2008-06-19$19.91/sh−500$9,955→ 2,119,931 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$20.00/sh−1,400$28,000→ 2,118,331 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.92/sh−100$1,992→ 2,119,831 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.90/sh−153,700$3,058,630→ 2,120,431 total(indirect: See Footnote)
GADICKE ANSBERT
10% Owner
Transactions
- Sale
Common Stock
2008-06-19$19.90/sh−153,700$3,058,630→ 2,120,431 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.91/sh−500$9,955→ 2,119,931 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.92/sh−100$1,992→ 2,119,831 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$20.00/sh−1,400$28,000→ 2,118,331 total(indirect: See Footnote)
MPM BIOVENTURES I LP
10% Owner
Transactions
- Sale
Common Stock
2008-06-19$19.92/sh−100$1,992→ 2,119,831 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.90/sh−153,700$3,058,630→ 2,120,431 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$19.91/sh−500$9,955→ 2,119,931 total(indirect: See Footnote) - Sale
Common Stock
2008-06-19$20.00/sh−1,400$28,000→ 2,118,331 total(indirect: See Footnote)
Footnotes (10)
- [F1]These shares were sold as follows: 68,391 shares by BB BioVentures, L.P. ("BBBV"), 9,220 shares by MPM BioVentures Parallel Fund, L.P. ("BV PF"), 815 shares by MPM Asset Management Investors 1999 LLC ("AM 1999"), 3,971 shares by MPM BioVentures III, L.P., ("BV III"), 59,073 shares by MPM BioVentures III-QP, L.P. ("BV III QP"), 4,993 shares held by MPM BioVentures III GmbH & Co. Beteiligungs KG ("BV KG"), 1,785 shares by MPM BioVentures III Parallel Fund, L.P. ("BV III PF"), 1,403 shares held by MPM Asset Management Investors 2004 BVIII LLC ("AM BV III"), 3,949 by MPM BioVentures III GP, LP ("BV III GP") and 100 by MPM Capital, L.P. ("MPM LP"). MPM BioVentures I, L.P. ("BV I") and MPM BioVentures I LLC ("BV I LLC") are the direct and indirect general partners of BV PF. BAB BioVentures L.P. ("BAB BV"), BAB BioVentures, N.V. ("BAB NV") and BV I LLC are the direct and indirect general partners of BBBV. Michael Steinmetz and Ansbert Gadicke are managers of AM 1999 and BV I LLC. BV III GP and MPM BioVentures III LLC ("BV III LLC") are the direct and indirect general partners of BV III, BV III QP, BV III PF and BV KG. Michael Steinmetz and Ansbert Gadicke are Series A members of BV III LLC and managers of AM BV III. Ansbert Gadicke has a controlling interest in MPM LP. Each Reporting Person disclaims beneficial ownership of all such shares except to the extent of their respective proportionate pecuniary interests therein.
- [F10]The shares are held as follows: 942,573 by BBBV, 127,068 by BV PF, 11,239 by AM 1999, 54,746 by BV III, 814,147 by BV III QP, 68,801 by BV KG, 24,588 by BV III PF, 19,354 by AM BV III, 54,447 by BV III GP and 1,368 by MPM LP. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of their respective proportionate pecuniary interest therein.
- [F2]The shares are held as follows: 943,507 by BBBV, 127,194 by BV PF, 11,251 by AM 1999, 54,801 by BV III, 814,953 by BV III QP, 68,868 by BV KG, 24,612 by BV III PF, 19,374 by AM BV III, 54,502 by BV III GP and 1,369 by MPM LP. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of their respective proportionate pecuniary interest therein.
- [F3]The shares were sold as follows: 222 by BBBV, 30 by BV PF, 3 by AM 1999, 13 by BV III, 192 by BV III QP, 16 by BV KG, 6 by BV III PF, 5 by AM BV III and 13 by BV III GP.
- [F4]The shares are held as follows: 943,285 by BBBV, 127,164 by BV PF, 11,248 by AM 1999, 54,788 by BV III, 814,761 by BV III QP, 68,852 by BV KG, 24,606 by BV III PF, 19,369 by AM BV III, 54,489 by BV III GP and 1,369 by MPM LP. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of their respective proportionate pecuniary interest therein.
- [F5]The shares were sold as follows: 44 by BBBV, 6 by BV PF, 1 by AM 1999, 3 by BV III, 38 by BV III QP, 3 by BV KG, 1 by BV III PF, 1 by AM BV III and 3 by BV III GP.
- [F6]The shares are held as follows: 943,241 by BBBV, 127,158 by BV PF, 11,247 by AM 1999, 54,785 by BV III, 814,723 by BV III QP, 68,849 by BV KG, 24,605 by BV III PF, 19,368 by AM BV III, 54,486 by BV III GP and 1,369 by MPM LP. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of their respective proportionate pecuniary interest therein.
- [F7]The shares were sold as follows: 44 by BBBV, 6 by BV PF, 1 by AM 1999, 3 by BV III, 38 by BV III QP, 3 by BV KG, 1 by BV III PF, 1 by AM BV III and 3 by BV III GP.
- [F8]The shares are held as follows: 943,197 by BBBV, 127,152 by BV PF, 11,246 by AM 1999, 54,782 by BV III, 814,685 by BV III QP, 68,846 by BV KG, 24,604 by BV III PF, 19,367 by AM BV III, 54,483 by BV III GP and 1,369 by MPM LP. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of their respective proportionate pecuniary interest therein.
- [F9]The shares were sold as follows: 624 by BBBV, 84 by BV PF, 7 by AM 1999, 36 by BV III, 538 by BV III QP, 45 by BV KG, 16 by BV III PF, 13 by AM BV III, 36 by BV III GP and 1 by MPM LP.
Documents
Issuer
Pharmasset Inc
CIK 0001301081
Entity typeother
Related Parties
1- filerCIK 0001263199
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 6:13 PM ET
- Size
- 29.4 KB